Concetta Ragone

发表

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy

L. Buonaguro, M. Tagliamonte, A. Petrizzo, 2021, Cancers.

Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity

G. Ciliberto, S. Costantini, A. Budillon, 2019, Scientific Reports.

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes

F. Buonaguro, L. Buonaguro, M. Tornesello, 2022, Journal of Translational Medicine.

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case

F. Buonaguro, L. Buonaguro, R. Penta, 2022, Journal of Translational Medicine.

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).

L. Vitagliano, F. Buonaguro, L. Buonaguro, 2021, Journal for ImmunoTherapy of Cancer.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, A. Hauschild, J. Malvehy, 2016, Journal of Translational Medicine.

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells

G. Botti, P. Ascierto, G. Ciliberto, 2017, Journal of experimental & clinical cancer research : CR.

Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells

M. L. Motti, M. Minopoli, Vincenzo Ingangi, 2019, Front. Oncol..

Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.

L. Buonaguro, M. Tagliamonte, A. Petrizzo, 2019, Cancer letters.

Novel Molecular Targets for Hepatocellular Carcinoma

F. Buonaguro, L. Buonaguro, S. Hadrup, 2021, Cancers.

Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion

G. Botti, G. Ciliberto, G. Scognamiglio, 2019, Journal of Experimental & Clinical Cancer Research.

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas

G. Botti, G. Botti, G. Ciliberto, 2017, Scientific Reports.

The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells

G. Botti, P. Grieco, D. Rea, 2016, Oncotarget.

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma

L. Fattore, R. Mancini, M. Acunzo, 2018, Cell Death & Differentiation.

Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells

P. Ascierto, G. Palmieri, M. L. Motti, 2018, International journal of oncology.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, David C. Smith, A. Hauschild, 2016, Journal of Translational Medicine.

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy

L. Vitagliano, L. Buonaguro, A. Caporale, 2021, Journal of translational medicine.

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides

F. Buonaguro, L. Buonaguro, A. Barbieri, 2021, Journal of translational medicine.

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response

L. Vitagliano, F. Buonaguro, L. Buonaguro, 2021, Frontiers in Immunology.

HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine

F. Buonaguro, L. Buonaguro, R. Penta, 2021, Frontiers in Immunology.

Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion

G. Botti, G. Ciliberto, G. Scognamiglio, 2019, Journal of experimental & clinical cancer research : CR.

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells

G. Botti, P. Ascierto, G. Ciliberto, 2017, Journal of experimental & clinical cancer research : CR.

Microorganisms-derived antigens for preventive anti-cancer vaccines.

F. Buonaguro, L. Buonaguro, M. Tornesello, 2023, Molecular aspects of medicine.

Molecular mimicry and cancer vaccine development

F. Buonaguro, L. Buonaguro, M. Tornesello, 2023, Molecular Cancer.

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma

L. Fattore, R. Mancini, M. Acunzo, 2018, Cell Death & Differentiation.

Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells

L. Buonaguro, A. Cusano, M. Minopoli, 2023, International journal of nanomedicine.

Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization

M. Tagliamonte, B. Cembrola, E. Cavalcanti, 2024, Frontiers in immunology.